Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BDSX vs $SRTA | Chartloom

Compare

$BDSX vs $SRTA

Biodesix Inc · Strata Critical Medical Inc

BDSX

Biodesix Inc

SRTA

Strata Critical Medical Inc

Compare $BDSX vs $SRTA

Comparing Biodesix Inc and Strata Critical Medical Inc

BDSXBiodesix Inc

SRTAStrata Critical Medical Inc

BDSXBiodesix Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.00x

Rev growth (TTM)

34.5%

YTD performance

271.4%

52W performance

224.2%

FCF yield

-8.2%

SRTAStrata Critical Medical Inc

Market cap

$370M

P/E (TTM)

9.17x

Forward P/E (NTM)

58.55x

Forward P/S (NTM)

1.16x

Rev growth (TTM)

18.8%

YTD performance

-13.2%

52W performance

-13.0%

FCF yield

-13.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDSX

SRTA

Detailed metrics comparison

BDSX

Biodesix Inc

SRTA

Strata Critical Medical Inc

Market Cap

BDSX$249M

SRTA$370M

Enterprise Value

BDSX$265M

SRTA$354M

Price

BDSX$23.99

SRTA$4.28

P/E Ratio

BDSXN/A

SRTA9.17x

P/S Ratio

BDSX2.41x

SRTA1.45x

EV/Sales

BDSX2.58x

SRTA1.38x

EV/EBITDA

BDSX0.00x

SRTA0.00x

P/B Ratio

BDSX30.02x

SRTA1.43x

P/FCF Ratio

BDSXN/A

SRTAN/A

EV/FCF

BDSX-13.01x

SRTA-7.16x

PEG Ratio

BDSXN/A

SRTAN/A

Forward P/E (NTM)

BDSXN/A

SRTA58.55x

Forward P/S (NTM)

BDSX2.00x

SRTA1.16x

Revenue (TTM)

BDSX$103M

SRTA$256M

Revenue Growth (YoY)

BDSX34.5%

SRTA18.8%

Forward Rev Growth

BDSX20.2%

SRTA12.1%

Gross Margin (TTM)

BDSX82.5%

SRTA-40.4%

Operating Margin (TTM)

BDSX0.0%

SRTA0.0%

EBITDA Margin (TTM)

BDSX-14.6%

SRTA-79.9%

Net Margin (TTM)

BDSX-27.0%

SRTA15.7%

FCF Margin (TTM)

BDSX-19.8%

SRTA-19.3%

Net Income (TTM)

BDSX$-28M

SRTA$40M

FCF (TTM)

BDSX$-20M

SRTA$-49M

EPS (TTM)

BDSX-$2.70

SRTA$0.47

ROE (TTM)

BDSX-16487.0%

SRTA14.3%

ROA (TTM)

BDSX-3033.0%

SRTA12.2%

ROIC (TTM)

BDSX-2700.0%

SRTA14.3%

Cash

BDSX$30M

SRTA$16M

Debt

BDSX$47M

SRTA$0

Net Cash/Debt

BDSX$-17M

SRTA$16M

Current Ratio (TTM)

BDSX2.85x

SRTA2.64x

Quick Ratio (TTM)

BDSX2.85x

SRTA1.45x

Debt/Equity (TTM)

BDSX5.12x

SRTA0.00x

Debt/Assets (TTM)

BDSX0.0%

SRTA0.0%

Interest Coverage (TTM)

BDSXN/A

SRTAN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

SRTA0.00x

Beta

BDSX0.60

SRTA2.57

52W Performance

BDSX224.2%

SRTA-13.0%

YTD Performance

BDSX271.4%

SRTA-13.2%

% from 52W High

BDSX-25.0%

SRTA-34.2%

% from 52W Low

BDSX356.1%

SRTA8.4%

Asset Turnover (TTM)

BDSX1.12x

SRTA0.78x

FCF Yield (TTM)

BDSX-8.2%

SRTA-13.4%

Earnings Yield (TTM)

BDSX-11.2%

SRTA10.9%

Dividend Yield (TTM)

BDSXN/A

SRTAN/A

Rule of 40

BDSX14.6

SRTA-0.5

EV/GP/RG

BDSX0.15

SRTAN/A

Ticker research

View BDSX research View SRTA research

Metric	BDSX Biodesix Inc	SRTA Strata Critical Medical Inc
Market & Valuation
Market Cap	$249M	$370M
Enterprise Value	$265M	$354M
Price	$23.99	$4.28
P/E Ratio	N/A	9.17x
P/S Ratio	2.41x	1.45x
EV/Sales	2.58x	1.38x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.02x	1.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.01x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	58.55x
Forward P/S (NTM)	2.00x	1.16x
Revenue & Growth
Revenue (TTM)	$103M	$256M
Revenue Growth (YoY)	34.5%	18.8%
Forward Rev Growth	20.2%	12.1%
Profitability
Gross Margin (TTM)	82.5%	-40.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-14.6%	-79.9%
Net Margin (TTM)	-27.0%	15.7%
FCF Margin (TTM)	-19.8%	-19.3%
Net Income (TTM)	$-28M	$40M
FCF (TTM)	$-20M	$-49M
EPS (TTM)	-$2.70	$0.47
ROE (TTM)	-16487.0%	14.3%
ROA (TTM)	-3033.0%	12.2%
ROIC (TTM)	-2700.0%	14.3%
Financial Health
Cash	$30M	$16M
Debt	$47M	$0
Net Cash/Debt	$-17M	$16M
Current Ratio (TTM)	2.85x	2.64x
Quick Ratio (TTM)	2.85x	1.45x
Debt/Equity (TTM)	5.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	2.57
52W Performance	224.2%	-13.0%
YTD Performance	271.4%	-13.2%
% from 52W High	-25.0%	-34.2%
% from 52W Low	356.1%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.78x
FCF Yield (TTM)	-8.2%	-13.4%
Earnings Yield (TTM)	-11.2%	10.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	-0.5
EV/GP/RG	0.15	N/A
Ticker research	View BDSX research	View SRTA research

Valuation

P/E Ratio

SRTA

9.17x

P/S Ratio

SRTA

1.45x

BDSX

2.41x

EV/FCF

BDSX

-13.01x

SRTA

-7.16x

Growth & revenue

Revenue Growth TTM

BDSX

34.5%

SRTA

18.8%

Forward Revenue Growth

BDSX

20.2%

SRTA

12.1%

Profitability & performance

Gross Margin

BDSX

82.5%

SRTA

-40.4%

ROE

SRTA

14.3%

BDSX

-16487.0%

FCF Yield %

BDSX

-8.2%

SRTA

-13.4%

52-Week Performance

BDSX

224.2%

SRTA

-13.0%

Detailed metrics comparison

BDSX

Biodesix Inc

SRTA

Strata Critical Medical Inc

Market Cap

BDSX$249M

SRTA$370M

Enterprise Value

BDSX$265M

SRTA$354M

Price

BDSX$23.99

SRTA$4.28

P/E Ratio

BDSXN/A

SRTA9.17x

P/S Ratio

BDSX2.41x

SRTA1.45x

EV/Sales

BDSX2.58x

SRTA1.38x

EV/EBITDA

BDSX0.00x

SRTA0.00x

P/B Ratio

BDSX30.02x

SRTA1.43x

P/FCF Ratio

BDSXN/A

SRTAN/A

EV/FCF

BDSX-13.01x

SRTA-7.16x

PEG Ratio

BDSXN/A

SRTAN/A

Forward P/E (NTM)

BDSXN/A

SRTA58.55x

Forward P/S (NTM)

BDSX2.00x

SRTA1.16x

Revenue (TTM)

BDSX$103M

SRTA$256M

Revenue Growth (YoY)

BDSX34.5%

SRTA18.8%

Forward Rev Growth

BDSX20.2%

SRTA12.1%

Gross Margin (TTM)

BDSX82.5%

SRTA-40.4%

Operating Margin (TTM)

BDSX0.0%

SRTA0.0%

EBITDA Margin (TTM)

BDSX-14.6%

SRTA-79.9%

Net Margin (TTM)

BDSX-27.0%

SRTA15.7%

FCF Margin (TTM)

BDSX-19.8%

SRTA-19.3%

Net Income (TTM)

BDSX$-28M

SRTA$40M

FCF (TTM)

BDSX$-20M

SRTA$-49M

EPS (TTM)

BDSX-$2.70

SRTA$0.47

ROE (TTM)

BDSX-16487.0%

SRTA14.3%

ROA (TTM)

BDSX-3033.0%

SRTA12.2%

ROIC (TTM)

BDSX-2700.0%

SRTA14.3%

Cash

BDSX$30M

SRTA$16M

Debt

BDSX$47M

SRTA$0

Net Cash/Debt

BDSX$-17M

SRTA$16M

Current Ratio (TTM)

BDSX2.85x

SRTA2.64x

Quick Ratio (TTM)

BDSX2.85x

SRTA1.45x

Debt/Equity (TTM)

BDSX5.12x

SRTA0.00x

Debt/Assets (TTM)

BDSX0.0%

SRTA0.0%

Interest Coverage (TTM)

BDSXN/A

SRTAN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

SRTA0.00x

Beta

BDSX0.60

SRTA2.57

52W Performance

BDSX224.2%

SRTA-13.0%

YTD Performance

BDSX271.4%

SRTA-13.2%

% from 52W High

BDSX-25.0%

SRTA-34.2%

% from 52W Low

BDSX356.1%

SRTA8.4%

Asset Turnover (TTM)

BDSX1.12x

SRTA0.78x

FCF Yield (TTM)

BDSX-8.2%

SRTA-13.4%

Earnings Yield (TTM)

BDSX-11.2%

SRTA10.9%

Dividend Yield (TTM)

BDSXN/A

SRTAN/A

Rule of 40

BDSX14.6

SRTA-0.5

EV/GP/RG

BDSX0.15

SRTAN/A

Ticker research

View BDSX research View SRTA research

Metric	BDSX Biodesix Inc	SRTA Strata Critical Medical Inc
Market & Valuation
Market Cap	$249M	$370M
Enterprise Value	$265M	$354M
Price	$23.99	$4.28
P/E Ratio	N/A	9.17x
P/S Ratio	2.41x	1.45x
EV/Sales	2.58x	1.38x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.02x	1.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.01x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	58.55x
Forward P/S (NTM)	2.00x	1.16x
Revenue & Growth
Revenue (TTM)	$103M	$256M
Revenue Growth (YoY)	34.5%	18.8%
Forward Rev Growth	20.2%	12.1%
Profitability
Gross Margin (TTM)	82.5%	-40.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-14.6%	-79.9%
Net Margin (TTM)	-27.0%	15.7%
FCF Margin (TTM)	-19.8%	-19.3%
Net Income (TTM)	$-28M	$40M
FCF (TTM)	$-20M	$-49M
EPS (TTM)	-$2.70	$0.47
ROE (TTM)	-16487.0%	14.3%
ROA (TTM)	-3033.0%	12.2%
ROIC (TTM)	-2700.0%	14.3%
Financial Health
Cash	$30M	$16M
Debt	$47M	$0
Net Cash/Debt	$-17M	$16M
Current Ratio (TTM)	2.85x	2.64x
Quick Ratio (TTM)	2.85x	1.45x
Debt/Equity (TTM)	5.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	2.57
52W Performance	224.2%	-13.0%
YTD Performance	271.4%	-13.2%
% from 52W High	-25.0%	-34.2%
% from 52W Low	356.1%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.78x
FCF Yield (TTM)	-8.2%	-13.4%
Earnings Yield (TTM)	-11.2%	10.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.6	-0.5
EV/GP/RG	0.15	N/A
Ticker research	View BDSX research	View SRTA research